ALAAROVELLA THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Aug 2026, 21:31 | Corporate Governance Statement | Company Administration | — | 03024 | |
| 20 Aug 2026, 21:28 | Appendix 4G | Company Administration | — | 03025 | |
| 20 Aug 2026, 21:27 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 17 Aug 2026, 21:59 | Notification regarding unquoted securities - ALA | Other | — | 06021 | |
| 12 Aug 2026, 23:11 | Investor Webinar Presentation | Presentations | — | 03026, 14014 | |
| 12 Aug 2026, 02:10 | Investor Webinar Registration | Presentations | — | 14014 | |
| 27 July 2026, 22:15 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 30 June 2026, 19:12 | Notice under Section 708A | Securities Administration | — | 06018 | |
| 30 June 2026, 19:08 | Notification of cessation of securities - ALA | Other | — | 06027 | |
| 30 June 2026, 19:06 | Application for quotation of securities - ALA | Other | — | 06020 | |
| 25 June 2026, 18:19 | First-In-Human Trial | Company Update | — | 11001 | |
| 10 June 2026, 19:09 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 10 June 2026, 00:01 | Turtle to Clinical Advisory Board&Fiorenza Lead Investigator | Company Administration | — | 12008 | |
| 26 May 2026, 19:26 | Notification of cessation of securities - ALA | Other | — | 06027 | |
| 8 May 2026, 18:33 | Notification of cessation of securities - ALA | Other | — | 06027 | |
| 7 May 2026, 20:20 | Final Director's Interest Notice x4 | Director Interests | — | 02010 | |
| 7 May 2026, 18:30 | Arovella Presents at ISCT Conference in Dublin | Company Update | — | 11001 | |
| 7 May 2026, 18:24 | Arovella Appoints Acting CEO | Other | MS | 12019 | |
| 4 May 2026, 20:00 | Board Refresh and CEO Resignation | Company Administration | MS | 12001, 12017, 12019 | |
| 1 May 2026, 20:22 | Initial Director's Interest Notice x4 | Director Interests | — | 02008 | |
| 29 Apr 2026, 01:58 | Appointment of 4x Non-Executive Directors | Company Administration | — | 12001 | |
| 29 Apr 2026, 01:51 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 27 Apr 2026, 18:54 | Notification regarding unquoted securities - ALA | Other | — | 06021 | |
| 23 Apr 2026, 18:30 | Notice Received Under Section 249D Withdrawn | Meetings & Governance | — | 08006, 12008 | |
| 23 Apr 2026, 18:21 | Proposed issue of securities - ALA | Securities Administration | — | 06013 | |
| 22 Apr 2026, 21:05 | Update Regarding Section 249D Notice | Company Administration | — | 12008 | |
| 20 Apr 2026, 20:01 | Arovella Presents Poster at AACR Annual Meeting | Company Update | — | 11001 | |
| 15 Apr 2026, 18:26 | ALA Receives Additional R&D Tax Rebate of $0.28 Million | Periodic Reports | — | 03014, 12008 | |
| 13 Apr 2026, 18:28 | Notification of cessation of securities - ALA | Other | — | 06027 | |
| 11 Apr 2026, 00:21 | Application for quotation of securities - ALA | Other | — | 06020 | |
| 11 Apr 2026, 00:20 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 11 Apr 2026, 00:19 | Notice received under section 249D of the Corporations Act | Company Administration | — | 12008 | |
| 1 Apr 2026, 20:54 | CLDN18.2 CAR iNKT Cell Preclinical Data Update | Company Update | MS | 11001 | |
| 16 Mar 2026, 21:27 | TGA Clears ALA-101 Trial Under CTN Scheme | Company Update | — | 11001 | |
| 20 Feb 2026, 01:57 | Half Year Report and Appendix 4D | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 19 Feb 2026, 19:30 | 20260219 ALA 708A Cleansing Notice | Securities Administration | — | 06018 | |
| 19 Feb 2026, 19:25 | Notification of cessation of securities - ALA | Other | — | 06027 | |
| 19 Feb 2026, 19:24 | Application for quotation of securities - ALA | Other | — | 06020 | |
| 16 Feb 2026, 19:25 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 16 Feb 2026, 19:23 | Application for quotation of securities - ALA | Other | — | 06020 | |
| 16 Feb 2026, 19:21 | Notification of cessation of securities - ALA | Other | — | 06027 | |
| 13 Feb 2026, 20:41 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 13 Feb 2026, 20:40 | Application for quotation of securities - ALA | Other | — | 06020 | |
| 10 Feb 2026, 00:58 | Final Director's Interest Notice x2 | Director Interests | — | 02010 | |
| 9 Feb 2026, 21:00 | Board Changes | Company Administration | — | 12001, 12017 | |
| 5 Feb 2026, 20:51 | Investor Presentation | Presentations | — | 03026 | |
| 5 Feb 2026, 19:42 | Letter from Managing Director and CEO | Letters & Addresses | — | 16002 | |
| 29 Jan 2026, 20:11 | ALA's IND FOR ALA-101 ACCEPTED BY THE U.S.FDA | Company Update | MS | 11001 | |
| 23 Jan 2026, 19:51 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 22 Jan 2026, 19:32 | Company Secretary/CFO Appointment/Resignation | Company Administration | — | 12007, 12008 |
1–50 of 99
1 / 2